New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required ....New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required dimensional stability, impermeability and wear resistance. Following sophisticated experiments of modified materials, the best candidates will be used in prototype devices, for final selection of the optimal materials for the new device.Read moreRead less
Synthesis of Novel Biomaterials for Drug delivery. A new UV radiation polymerisation technique utilising charge-transfer complexes is adopted for synthesising novel hydrogels, a group of biomaterials for drug delivery. This work is significant as charge-transfer complexes, pertinent to the formation of hydrogels, form copolymers within the hydrogel matrices. This eliminates using costly, yet undesirable photo-initiators (PI), thus rendering the hydrogels as cleaner (PI-free) and more economical ....Synthesis of Novel Biomaterials for Drug delivery. A new UV radiation polymerisation technique utilising charge-transfer complexes is adopted for synthesising novel hydrogels, a group of biomaterials for drug delivery. This work is significant as charge-transfer complexes, pertinent to the formation of hydrogels, form copolymers within the hydrogel matrices. This eliminates using costly, yet undesirable photo-initiators (PI), thus rendering the hydrogels as cleaner (PI-free) and more economical in production; the products present themselves as ideal treatment methods in the controlled-release of drugs, specifically targeting localised pathological sites of interest. The research findings will be invaluable to medical practices, leading to the creation of new industries in Australia.
Read moreRead less
Functional drug-releasing polymer nano-composites for preventing medical device infection and encrustation. By developing new methodologies for producing functional biomaterials, this research will benefit Australia by continuing our high profile in this research field and by producing economic benefits arising from development and export of materials technologies to the major user groups in USA and Europe. With our demonstrated linkages with Australian based biomaterials developers at CSIRO an ....Functional drug-releasing polymer nano-composites for preventing medical device infection and encrustation. By developing new methodologies for producing functional biomaterials, this research will benefit Australia by continuing our high profile in this research field and by producing economic benefits arising from development and export of materials technologies to the major user groups in USA and Europe. With our demonstrated linkages with Australian based biomaterials developers at CSIRO and University of Queensland, as well as with companies involved in the commercialisation of polyurethane based medical devices (Aortech P/L), this group is well placed to continue the research at a more applied level once the early basic stage is complete.Read moreRead less
Oral Insulin Delivery facilitated by Enteric Coating using Dense Gas Technologies. Insulin dependant diabetes is a rapidly growing disease. The current method for insulin delivery to the patient is by injection, which is inconvenient. Oral delivery of insulin is a more acceptable method. It is proposed to develop a dense gas technique to coat insulin with a pH sensitive polymer to protect it from the acidic environment of the stomach. Insulin can then be released at the high pH of the intestin ....Oral Insulin Delivery facilitated by Enteric Coating using Dense Gas Technologies. Insulin dependant diabetes is a rapidly growing disease. The current method for insulin delivery to the patient is by injection, which is inconvenient. Oral delivery of insulin is a more acceptable method. It is proposed to develop a dense gas technique to coat insulin with a pH sensitive polymer to protect it from the acidic environment of the stomach. Insulin can then be released at the high pH of the intestine when the polymer is dissolved. Particle size control is feasible by dense gas processes by manipulating operating parameters. Advantages include low residual solvent and manufacture at ambient temperatures.Read moreRead less
Understanding glycopolymer interactions with the extracellular matrix. This project aims to advance knowledge of the biochemical and biophysical structure of the endothelial glycocalyx, a dynamic cell surface extracellular matrix rich in proteoglycans and glycosaminoglycans. It will be the first to explore how charged glycopolymers interact with this dynamic interface with the goal to develop a model of the glycocalyx lifecycle. This project is expected to enable the transfer of skills, knowledg ....Understanding glycopolymer interactions with the extracellular matrix. This project aims to advance knowledge of the biochemical and biophysical structure of the endothelial glycocalyx, a dynamic cell surface extracellular matrix rich in proteoglycans and glycosaminoglycans. It will be the first to explore how charged glycopolymers interact with this dynamic interface with the goal to develop a model of the glycocalyx lifecycle. This project is expected to enable the transfer of skills, knowledge and ideas as well as advanced research and industrial training for young scientists. Knowledge derived from this project is expected to enable future innovation in molecules with tailored interactions with the glycocalyx with significant benefits for researchers, manufacturers and end users. Read moreRead less
Drug Delivery Devices : Hydrogels manufactured utilising Dense Gas Technologies. Many drugs are rapidly eliminated from the human body, and would benefit from being released over a long period of time. In this study, formulations to deliver drugs will be developed, using hydrogels: highly cross-linked, water saturated polymers. The polymers to be investigated are based on ingredients suitable for ingestion. Hydrogels are in common use as external therapeutic devices, such as contact lenses or wo ....Drug Delivery Devices : Hydrogels manufactured utilising Dense Gas Technologies. Many drugs are rapidly eliminated from the human body, and would benefit from being released over a long period of time. In this study, formulations to deliver drugs will be developed, using hydrogels: highly cross-linked, water saturated polymers. The polymers to be investigated are based on ingredients suitable for ingestion. Hydrogels are in common use as external therapeutic devices, such as contact lenses or wound dressings. However, hydrogels are not commonly in use as ingested drug delivery devices due to problems with the existing technologies, such as toxicity of ingredients. These problems will be addressed in this study.Read moreRead less
Carbon Dioxide: Solvent, Carrier and Reagent, for novel polymer networks with controlled nano-architectures. The proposed environmentally friendly technology has broad applications for improving properties of various polymeric matrices used for biomedical applications. The process developed would value-add for manufacturing biomedical polymeric devices in Australia with licensing of existing fabrication methods as a best option. Moreover, the leading-edge polymer technology developed would mini ....Carbon Dioxide: Solvent, Carrier and Reagent, for novel polymer networks with controlled nano-architectures. The proposed environmentally friendly technology has broad applications for improving properties of various polymeric matrices used for biomedical applications. The process developed would value-add for manufacturing biomedical polymeric devices in Australia with licensing of existing fabrication methods as a best option. Moreover, the leading-edge polymer technology developed would minimise the organic solvent consumption and will attract business from international polymer and biotechnology companies for production of implant and drug delivery devices. The development of world-class research provides Australia with recognition as a world leader in the field and broadens the knowledge based of Australian scientist and engineers.Read moreRead less
Multiscale modelling and nondeterministic optimisation for reliable stents. This project aims to study modelling and optimisation for a more reliable design of intravascular stents. Intravascular stents are a class of lifelong micro-devices to support blood vessel for restoring circulation. Despite its remarkable initial outcome, the high rate of long-term mechanical failure remains a major concern. This project will tackle plasticity, fatigue damage and fracture across different length scales. ....Multiscale modelling and nondeterministic optimisation for reliable stents. This project aims to study modelling and optimisation for a more reliable design of intravascular stents. Intravascular stents are a class of lifelong micro-devices to support blood vessel for restoring circulation. Despite its remarkable initial outcome, the high rate of long-term mechanical failure remains a major concern. This project will tackle plasticity, fatigue damage and fracture across different length scales. The proposed optimisation is expected to minimise failure, thereby enhancing the longevity and reliability of stent therapy. This will have significant benefits, such as accommodating variations in stents and service conditions for achieving a long-lasting and reliable therapeutical outcome.Read moreRead less
Hermetic bonding of biomedical polymers for cardiac-assist devices. The use of a polymeric ventricular assist device will bring a much better quality of life to patients with end-stage heart failure. The project will address the remaining challenge, the creation of a hermetic polymer seal, enabling the development of a small, light and highly efficient heart pump. The project has the potential to improve the lives of many Australians as our demographic profile shifts towards older people. Patie ....Hermetic bonding of biomedical polymers for cardiac-assist devices. The use of a polymeric ventricular assist device will bring a much better quality of life to patients with end-stage heart failure. The project will address the remaining challenge, the creation of a hermetic polymer seal, enabling the development of a small, light and highly efficient heart pump. The project has the potential to improve the lives of many Australians as our demographic profile shifts towards older people. Patients with advanced heart failure will live longer, with a higher quality of life. It will assist heart failure sufferers to remain productive members of our community, because many people who use the device will be fit to return to work.Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC170100016
Funder
Australian Research Council
Funding Amount
$3,123,492.00
Summary
ARC Training Centre for Personalised Therapeutics Technologies. The ARC Training Centre for Personalised Therapeutics Technologies aims to create and develop the skills and technology to benefit from the transformative impacts that cell/organ-on-a-chip technology will have on the medtech/pharma industries. By combining microfluidics-based/real-time technologies with personalised medicine the Training Centre will provide industry growth opportunities through improved screening of potential therap ....ARC Training Centre for Personalised Therapeutics Technologies. The ARC Training Centre for Personalised Therapeutics Technologies aims to create and develop the skills and technology to benefit from the transformative impacts that cell/organ-on-a-chip technology will have on the medtech/pharma industries. By combining microfluidics-based/real-time technologies with personalised medicine the Training Centre will provide industry growth opportunities through improved screening of potential therapeutics. The use of an individual patient’s cellular and molecular research findings will ultimately enable personalised diagnostic and therapeutic decisions.Read moreRead less